Prot# IPM3001: A Phase III Multicenter, International, Randomized, Double-Blind, Placebo-Controlled Study of Doxorubicin Plus Palifosfamide-Tris Vs. Doxorubicin Plus Placebo in Patients With Front-Line Metastatic Soft Tissue Sarcoma. The PICASSO III Stud